Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Carboxypeptidase E is a Sorting Receptor for the Regulated Secretory Pathway

The membrane-bound form of Carboxypeptidase E (CPE) was identified as a sorting receptor for the regulated secretory pathway through studies carried out in our lab. We have generated a molecular model of CPE, and structural alignment with other carboxypeptidases revealed a putative sorting signal binding domain that is independent of the enzymatic site. In order to study the sorting signal binding site, we generated a number of mutant forms of CPE and expressed them in insect Sf9 cells using a baculovirus vector. We developed a binding assay using the membranes from infected cells expressing CPE, and were able to map a sorting signal binding site in CPE. Two basic amino acid residues, Arg255 and Lys260, were found to be critical for binding to the acidic amino acids on the sorting signal of pro-opiomelanocortin (POMC), p roinsulin and brain derived neurotrophic factor (BDNF). In the anterior loop of pituitary and neurons derived from CPE knock out mice, the regulated secretion of BDNF was impaired.

A molecular model of CPE, and structural alignment with other carboxypeptidases revealing a putative sorting signal binding domain that is independent of the enzymatic site.
A binding assay using the membranes from infected cells expressing CPE.